Metoclopramide Hydrochloride 甲氧氯普胺盐酸盐
CAS 7232-21-5 MFCD00058011
化学结构图
SMILES: CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl
化学属性
| Mol. Formula | C14H22ClN3O2·HCl |
|---|---|
| Mol. Weight | 336 |
| Density | 1.422 |
别名和识别编码
| Chemical Name | Metoclopramide Hydrochloride |
|---|---|
| MDL Number | MFCD00058011 |
| CAS Number | 7232-21-5 |
| EC Number | 230-634-5 |
| Beilstein Registry Number | 2384789 |
| PubChem Substance ID | 23659 |
| Synonym | 甲氧氯普胺 盐酸盐 Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-, 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide hydrochloride |
| Chemical Name Translation | 甲氧氯普胺盐酸盐 |
| InChIKey | RVFUNJWWXKCWNS-UHFFFAOYSA-N |
| Wiswesser Line Notation | 2N2&2MVR DZ CG FO1 &GH |
| InChI | InChI=1S/C14H22ClN3O2.ClH/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H |
| LabNetwork Molecule ID | LN01299785 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Antagonists, Approved Therapeutics/Drug Candidates, Baxter, Biochemicals and Reagents, Dopaminargics - Antagonists, Dopaminergics, GPCR Modulators, GPCR Proteins, M
- {SNA} Antagonists, Approved Therapeutics/Drug Candidates, Baxter, Bioactive Small Molecules, Biochemicals and Reagents,
安全信息
GHS Symbol
- S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后，立即用大量水冲洗并征求医生意见；
- S36 Wear suitable protective clothing 穿戴适当的防护服；
- S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护；
- R22 Harmful if swallowed 吞咽有害
- R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
- P281 Use personal protective equipment as required. 使用所需的个人防护装备。
- P305+P351+P338
- H302 Harmful if swallowed 吞食有害
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - man DOSE/DURATION : 1 mg/kg/2D-I TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Behavioral - muscle contraction or spasticity REFERENCE : BJCPAT British Journal of Clinical Practice. (Medical News Group, 1 Bedford St., London WC2E 9HD, UK) V.10(10)- 1956- Volum
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - man DOSE/DURATION : 1161 mg/kg/2D-I TOXIC EFFECTS : Behavioral - muscle contraction or spasticity Lungs, Thorax, or Respiration - dyspnea REFERENCE : SMJOAV Southern Medical Journal. (Southern Medical Assoc., POB 2446, Birmingham, AL 35205) V.1- 1908- Volume(issue)/page/year: 76,817,1983
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - woman DOSE/DURATION : 2400 ug/kg/3D-I TOXIC EFFECTS : Behavioral - tremor Behavioral - rigidity (including catalepsy) Behavioral - muscle contraction or spasticity REFERENCE : CMAJAX Canadian Medical Association Journal. (Canadian Medical Assoc., POB 8650, Ottawa, ON K1G 0G8, Canada) V.1- 1911- Volume(issue)/page/year: 126,23,1982
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - man DOSE/DURATION : 400 ug/kg/16H-I TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor Behavioral - rigidity (including catalepsy) REFERENCE : AACRAT Anesthesia and Analgesia (New York). (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.36- 1957- Volume(issue)/page/year: 66,274,1987
京ICP备2020036287号